CSIMarket Company Name, Ticker, Suppliers, else..
 
Elevai Labs Inc  (NASDAQ: ELAB)
Other Ticker:  
 
 
Price: $3.1000 $1.12 56.566%
Day's High: $4.07 Week Perf: 45.54 %
Day's Low: $ 2.78 30 Day Perf: 21.09 %
Volume (M): 77,204 52 Wk High: $ 4.07
Volume (M$): $ 239,333 52 Wk Avg: $0.71
Open: $3.96 52 Wk Low: $0.01



 Market Capitalization (Millions $) 69
 Shares Outstanding (Millions) 22
 Employees -
 Revenues (TTM) (Millions $) 556
 Net Income (TTM) (Millions $) -786
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 11

Elevai Labs Inc
Elevai Labs Inc is a technology company that specializes in artificial intelligence and machine learning solutions. They develop advanced algorithms and software tools for various industries, including healthcare, finance, and retail. Elevai Labs aims to provide organizations with cutting-edge AI technologies to automate processes, gain insights from data, and enhance decision-making capabilities. They focus on creating scalable and customizable solutions that can be integrated into existing systems seamlessly.


   Company Address: 120 Newport Center Drive Newport Beach 92660 CA
   Company Phone Number: 794-4940   Stock Exchange / Ticker: NASDAQ ELAB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABUS      % 
ASMB      % 
BMY      % 
ENTA      % 
PCRX      % 
VRTX      % 
• View Complete Report
   



Stock Market Announcement

PMGC Holdings Inc. Positions for Growth with Skincare Subsidiary Sale and Strategic Share Exchange Offer through Elevai Labs Inc.,

Published Thu, Jan 2 2025 8:55 PM UTC

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth StrategyIn a move that highlights its commitment to growth and innovation, PMGC Holdings Inc. has announced a strategic shift following the recent sale of its skincare subsidiary. The transaction, aimed at streamlining operations and enhancing overall corporate focus, aligns with the company?s eff...
Merger and Acquisition

Carmell and PMGC Holdings Team Up to Acquire Elevai Skincare Amid Promising Advances in Obesity Treatment and AI Innovations

Published Thu, Jan 2 2025 1:01 PM UTC

In a transformative move for both the beauty and healthcare industries, Carmell and PMGC Holdings Inc. have officially announced the execution of a definitive agreement to acquire Elevai Skincare, a notable leader in physician-dispensed exosome skin and hair care products. This acquisition aligns with ongoing trends in personalized health solutions, focusing on innovative an...
Product Service News

The Next Frontier in Obesity Treatment Elevai Biosciences EL-22 Targets Fat Loss Amid Skepticism

Published Tue, Dec 31 2024 12:00 PM UTC

In an era marked by rising obesity rates and a relentless quest for effective weight-loss therapies, Elevai Biosciences, a subsidiary of Elevai Labs Inc., has announced a promising regulatory pathway for its innovative drug, EL-22. This pioneering therapy is designed not only to promote fat loss but also to prioritize muscle preservation, a critical aspect often overlooked i...
Shares

Elevai Labs Inc. Launches Strategic Share Exchange as Part of $8 Million Growth Initiative,

Published Fri, Oct 4 2024 9:09 PM UTC

Elevai Labs Inc. Expands Financial Strategies with Share Exchange Offer Amidst $8 Million Public OfferingElevai Labs Inc., a pioneering entity in the biopharmaceutical sector focused on the innovative applications of exosome technology, has announced an ambitious plan to exchange up to 15,000,000 shares of its common stock for non-tradable, locked-up Series B preferred stock...
Clinical Study

Elevai Labs Pioneering the Future of Skincare and Hair Restoration with Exosome Technology

Published Wed, Oct 2 2024 12:31 PM UTC

The landscape of skincare is shifting dramatically with the emergence of advanced biotechnological innovations. Elevai Labs Inc., through its subsidiary Elevai Skincare Inc., is at the forefront of this transformation, leveraging proprietary exosome technology to redefine approaches to skin and hair health. Recent announcements regarding multiple clinical studies and the pos...






Elevai Labs Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com